BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gordon SC, Trudeau S, Li J, Zhou Y, Rupp LB, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Boscarino JA, Daida YG, Schmidt MA, Lu M; CHeCS investigators. Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States. J Clin Gastroenterol 2019;53:40-50. [PMID: 28737649 DOI: 10.1097/MCG.0000000000000872] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Jafri SM, Gordon SC. Epidemiology of Hepatitis C. Clin Liver Dis (Hoboken) 2018;12:140-2. [PMID: 30988931 DOI: 10.1002/cld.783] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
2 Moorman AC, Rupp LB, Gordon SC, Zhong Y, Xing J, Lu M, Boscarino JA, Schmidt MA, Daida YG, Teshale EH, Spradling PR, Holmberg SD; CHeCS Investigators. Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings. Infect Dis Clin North Am. 2018;32:253-268. [PMID: 29778254 DOI: 10.1016/j.idc.2018.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
3 Alkrekshi A, Tamaskar I. Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus Infection. Oncologist 2021;26:e827-30. [PMID: 33655663 DOI: 10.1002/onco.13739] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nguyen DB, Bixler D, Patel PR. Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention. Semin Dial 2019;32:127-34. [PMID: 30569604 DOI: 10.1111/sdi.12761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]